Sullivan & Worcester and Hogan Lovells US advised Plus Therapeutics, while Sichenzia Ross Ference Carmel represented D. Boral Capital on the offering. Plus Therapeutics, Inc. (Nasdaq:...
Sullivan & Worcester and Hogan Lovells US advised Plus Therapeutics, while Sichenzia Ross Ference Carmel represented D. Boral Capital on the offering. Plus Therapeutics, Inc. (Nasdaq:...